Erythrodermic Psoriasis

Definition & Scope - Fiery Full-Body Flare

• Widespread, fiery erythema and scaling covering >90% of Body Surface Area (BSA).
• A severe, potentially life-threatening psoriatic variant; considered a dermatological emergency.
• Types:
  • Acute: Sudden onset, often precipitated by triggers (e.g., steroid withdrawal, infection).
  • Chronic: Develops gradually or from unstable plaque psoriasis.

⭐ Erythrodermic psoriasis is a dermatological emergency defined by erythema and scaling affecting >90% of the body surface area (BSA).

Etiopathogenesis - Sparking the Inferno

• Common Triggers:
  • Systemic/potent topical steroid withdrawal.
  • Infections (e.g., streptococcal, HIV).
  • Drugs: 📌 L.A.B. (Lithium, Antimalarials, Beta-blockers); also NSAIDs, interferons.
  • Systemic illness, hypocalcemia, stress, Koebner phenomenon.
• Underlying Psoriatic Mechanisms:
  • Exaggerated Th1/Th17 pathway activation.
  • Massive release of pro-inflammatory cytokines (TNF-α, IL-17, IL-23).
  • Widespread vasodilation & ↑ capillary permeability.

⭐ Sudden withdrawal of systemic corticosteroids or potent topical steroids is a notorious precipitant for erythrodermic psoriasis.

Clinical Features - Head-to-Toe Red

• Diffuse, fiery erythema: Covers ≥90% of body surface area (BSA).
• Generalized scaling: Fine or large, silvery scales; often exfoliative.
• Severe pruritus or pain: Intense itching or burning sensation.
• Systemic symptoms:
  • Fever, chills, malaise.
  • Tachycardia, peripheral edema.
• Lymphadenopathy: Generalized, non-tender lymph node enlargement.
• Nail changes: Onycholysis, subungual hyperkeratosis, pitting, Beau's lines.

⭐ Patients often experience significant systemic symptoms, including fever, chills, malaise, and severe pruritus or skin pain, highlighting the systemic impact beyond skin.

Diagnosis & DDx - Identifying the Culprit

• Clinical Diagnosis: Primarily based on history; pre-existing psoriasis is common but not universal.
• Skin Biopsy: May show psoriatic features (e.g., parakeratosis, Munro's microabscesses), but can be non-specific in erythroderma. Crucial to rule out other causes.

Differential Diagnosis (DDx) Highlights:

Management Strategy - Dousing the Flames

Erythrodermic psoriasis necessitates urgent hospitalization.

• Supportive Care (Crucial):
  • Maintain fluid and electrolyte balance.
  • Ensure strict temperature regulation.
  • Provide high-protein nutritional support.
  • Apply bland, liberal emollients frequently.
• Systemic Therapy (Initiate Promptly):
  • First-line options:
    • Cyclosporine: 3-5 mg/kg/day (rapid onset).
    • Methotrexate: Weekly; monitor for hepatotoxicity.
    • Infliximab: For severe, acute cases requiring rapid control.
  • Second-line options:
    • Acitretin: Teratogenic; use cautiously.
    • Other biologics: e.g., Ustekinumab, Secukinumab.
• ⚠️ Key Precaution: Avoid systemic steroids if possible due to significant risk of rebound phenomenon.

⭐ Urgent hospitalization and supportive care are paramount; methotrexate, cyclosporine, or infliximab are key systemic agents, with infliximab often favored for rapid control in acute severe cases.

High‑Yield Points - ⚡ Biggest Takeaways

• Generalized erythema and fine scaling involving >90% Body Surface Area (BSA); a dermatological emergency.
• Often precipitated by abrupt systemic steroid withdrawal in patients with pre-existing psoriasis.
• Systemic features include fever, chills, malaise, and significant skin pain or pruritus.
• Carries high risk of life-threatening complications: hypothermia, dehydration, electrolyte imbalance, secondary infections, high-output cardiac failure.
• Requires urgent hospitalization; management involves supportive care, and systemic agents like cyclosporine, methotrexate, or biologics.